FR2647809B1 - OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES - Google Patents

OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES

Info

Publication number
FR2647809B1
FR2647809B1 FR8907354A FR8907354A FR2647809B1 FR 2647809 B1 FR2647809 B1 FR 2647809B1 FR 8907354 A FR8907354 A FR 8907354A FR 8907354 A FR8907354 A FR 8907354A FR 2647809 B1 FR2647809 B1 FR 2647809B1
Authority
FR
France
Prior art keywords
hiv
viruses
genome
amplification
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8907354A
Other languages
French (fr)
Other versions
FR2647809A1 (en
Inventor
Maurice Moncany
Luc Montagnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut Pasteur de Lille
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut Pasteur de Lille
Priority to FR8907354A priority Critical patent/FR2647809B1/en
Priority to CA002585164A priority patent/CA2585164C/en
Priority to AT06013029T priority patent/ATE423856T1/en
Priority to DK05014676T priority patent/DK1642987T3/en
Priority to PCT/FR1990/000393 priority patent/WO1990015066A2/en
Priority to DK07025195.4T priority patent/DK2011888T3/en
Priority to ES06013029T priority patent/ES2321326T3/en
Priority to DK97110543T priority patent/DK0806484T3/en
Priority to DE05014676T priority patent/DE05014676T1/en
Priority to EP97110543A priority patent/EP0806484B1/en
Priority to AT97110543T priority patent/ATE323183T1/en
Priority to SG1996004845A priority patent/SG47868A1/en
Priority to ES05014676T priority patent/ES2275451T3/en
Priority to ES90401520T priority patent/ES2139567T3/en
Priority to AT90401520T priority patent/ATE185379T1/en
Priority to CA002062829A priority patent/CA2062829C/en
Priority to AT05014676T priority patent/ATE404699T1/en
Priority to DK90401520T priority patent/DK0403333T3/en
Priority to DE69034265T priority patent/DE69034265D1/en
Priority to DE69034260T priority patent/DE69034260D1/en
Priority to EP05014676A priority patent/EP1642987B1/en
Priority to DE69034267T priority patent/DE69034267D1/en
Priority to EP90401520A priority patent/EP0403333B1/en
Priority to CA002685262A priority patent/CA2685262A1/en
Priority to ES07025195T priority patent/ES2315215T1/en
Priority to DK06013029T priority patent/DK1715064T3/en
Priority to DE07025195T priority patent/DE07025195T1/en
Priority to EP06013029A priority patent/EP1715064B1/en
Priority to DE69034220T priority patent/DE69034220T2/en
Priority to EP07025195A priority patent/EP2011888B1/en
Priority to JP50891190A priority patent/JP3428012B2/en
Priority to DE69033311T priority patent/DE69033311T2/en
Priority to AT07025195T priority patent/ATE466111T1/en
Priority to ES97110543T priority patent/ES2262166T3/en
Publication of FR2647809A1 publication Critical patent/FR2647809A1/en
Application granted granted Critical
Publication of FR2647809B1 publication Critical patent/FR2647809B1/en
Priority to US08/160,465 priority patent/US5688637A/en
Priority to US08/472,928 priority patent/US7078516B1/en
Priority to US08/895,231 priority patent/US5786177A/en
Priority to US09/092,077 priority patent/US6194142B1/en
Priority to JP11270165A priority patent/JP2000093187A/en
Priority to GR990403346T priority patent/GR3032261T3/en
Priority to US10/862,363 priority patent/US7759477B2/en
Priority to US11/203,127 priority patent/US7777020B2/en
Priority to HK07103317.3A priority patent/HK1097574A1/en
Priority to HK09100744.0A priority patent/HK1125136A1/en
Priority to HK06110565.8A priority patent/HK1092839A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
FR8907354A 1989-06-02 1989-06-02 OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES Expired - Lifetime FR2647809B1 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
FR8907354A FR2647809B1 (en) 1989-06-02 1989-06-02 OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
CA002585164A CA2585164C (en) 1989-06-02 1990-06-05 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses
AT06013029T ATE423856T1 (en) 1989-06-02 1990-06-05 NUCLEOTIDE SEQUENCES OF HIV-1, HIV-2 AND SIV RETROVIRUS GENOMES, THEIR USE FOR AMPLIFYING POL SEQUENCES OF THESE RETROVIRUSES AND FOR IN VITRO DIAGNOSTIC INFECTIONS CAUSED BY THESE VIRUSES
DK05014676T DK1642987T3 (en) 1989-06-02 1990-06-05 Nucleotide sequences formed from the genomes of the retroviruses HIV-1, HIV-2 and SIV as well as their use in propagating these viral genomes and in vitro diagnosis of infections derived from these viruses
PCT/FR1990/000393 WO1990015066A2 (en) 1989-06-02 1990-06-05 Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses
DK07025195.4T DK2011888T3 (en) 1989-06-02 1990-06-05 Nucleotide sequences resulting from the genome of HIV-1, and the SIV retroviruses and their applications, in particular, for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of infections caused by these viruses
ES06013029T ES2321326T3 (en) 1989-06-02 1990-06-05 NUCLEOTIDIC SEQUENCES FROM THE GENOMA OF RETROVIRUSES OF HIV-1, HIV-2 AND VIS TYPE, AND THEIR APPLICATIONS SPECIFICALLY FOR THE AMPLIFICATION OF POL RULES OF THESE GENOMES OF THESE RETROVIRUSES AND FOR THE INVITED DIAGNOSIS OF INFECTION INFECTION.
DK97110543T DK0806484T3 (en) 1989-06-02 1990-06-05 Synthesis of proteins or polypeptides encoded by a nucleotide sequence of HIV-1, HIV-2 or SIV.
DE05014676T DE05014676T1 (en) 1989-06-02 1990-06-05 Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus genomes, their use for amplification of these retroviruses and for in vitro diagnostics of these viruses caused infections
EP97110543A EP0806484B1 (en) 1989-06-02 1990-06-05 Synthesis of proteins or polypeptides encoded by a sequence of HIV-1, HIV-2 or SIV.
AT97110543T ATE323183T1 (en) 1989-06-02 1990-06-05 PROTEIN OR POLYPEPTIDE SYNTHESIS ENCODED BY A NUCLIC ACID SEQUENCE OF HIV-1, HIV-2 OR SIV.
SG1996004845A SG47868A1 (en) 1989-06-02 1990-06-05 Nucleotide sequences erived from the genome of hiv-1 hiv-2 and siv type retroviruses and their applications especially for the amplification of the genomes of these (pls see pf1 for
ES05014676T ES2275451T3 (en) 1989-06-02 1990-06-05 NUCLEOTIDIC SEQUENCES FROM THE GENOMA OF RETROVIRUSES OF HIV-1, HIV-2 AND SIV TYPE, AND THEIR APPLICATIONS SPECIFICALLY FOR THE AMPLIFICATION OF THE GENES OF THESE RETROVIRUSES AND FOR THE IN VITRO DIAGNOSIS OF THE INFECTIONS DUE TO THESE.
ES90401520T ES2139567T3 (en) 1989-06-02 1990-06-05 NUCLEOTIDIC SEQUENCES FROM THE GENE OF RETROVIRUSES OF THE HIV-1 TYPE AND ITS APPLICATIONS FOR THE AMPLIFICATION OF THE GENOMES OF THESE RETROVIRUSES AND FOR THE IN VITRO DIAGNOSIS OF INFECTIONS PRODUCED BY THESE VIRUSES.
AT90401520T ATE185379T1 (en) 1989-06-02 1990-06-05 NUCLEOTIDE SEQUENCES OF THE GENOME OF RETROVIRUSES OF THE TYPES OF HIV-1, HIV-2 AND SIV, THEIR USES FOR THE AMPLIFICATION OF THESE GENOMES AND IN VITRO DIAGNOSIS OF THESE VIRAL INFECTIONS
CA002062829A CA2062829C (en) 1989-06-02 1990-06-05 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses
AT05014676T ATE404699T1 (en) 1989-06-02 1990-06-05 NUCLEOTIDE SEQUENCES OF HIV-1, HIV-2 AND SIV RETROVIRUS GENOMES, THEIR USE FOR AMPLIFICATION OF THESE RETROVIRUSES AND FOR IN VITRO DIAGNOSTICS OF INFECTIONS CAUSED BY THESE VIRUSES
DK90401520T DK0403333T3 (en) 1989-06-02 1990-06-05 Nucleotide sequences derived from the genome of HIV-1, HIV-2 and SIV retroviruses and their use, preferably for
DE69034265T DE69034265D1 (en) 1989-06-02 1990-06-05 Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus genomes, their use to amplify pol sequences of these retroviruses, and in vitro diagnostics of these viruses
DE69034260T DE69034260D1 (en) 1989-06-02 1990-06-05 Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus genomes, their use for amplification of these retroviruses, and for in vitro diagnostics of these viruses
EP05014676A EP1642987B1 (en) 1989-06-02 1990-06-05 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
DE69034267T DE69034267D1 (en) 1989-06-02 1990-06-05 Nucleotide sequences of the genome of HIV-1, HIV-2 and SIV retroviruses and their applications, in particular for the amplification of genomes of these retroviruses and for the in-vitro diagnosis of infections caused by these viruses
EP90401520A EP0403333B1 (en) 1989-06-02 1990-06-05 Nucleotide sequences of retroviral genomes of types HIV-I, HIV-2 and SIV, their uses for the amplification of these genomes and diagnosis in vitro of these viral infections
CA002685262A CA2685262A1 (en) 1989-06-02 1990-06-05 Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses
ES07025195T ES2315215T1 (en) 1989-06-02 1990-06-05 NUCLEOTIDIC SEQUENCES OF THE RETROVIRUS GENOME TYPE HIV-1, HIV-2, AND SIV AND ITS APPLICATIONS, IN PARTICULAR FOR THE AMPLIFICATION OF GENES OF THESE RETROVIRUSES AND FOR THE IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES.
DK06013029T DK1715064T3 (en) 1989-06-02 1990-06-05 Nucleotide sequences from HIV-1, HIV-2 and SIV retroviral genomes as well as their use for amplifying pole sequences from these retroviruses and for in vitro diagnosis of infections caused by these viruses
DE07025195T DE07025195T1 (en) 1989-06-02 1990-06-05 Nucleotide sequences of the genome of HIV-1, HIV-2 and SIV retroviruses and their applications, in particular for the amplification of genomes of these retroviruses and for the in-vitro diagnosis of infections caused by these viruses
EP06013029A EP1715064B1 (en) 1989-06-02 1990-06-05 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of pol sequences in these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
DE69034220T DE69034220T2 (en) 1989-06-02 1990-06-05 Nucleotide sequences of HIV-1, HIV-2 and SIV retrovirus taken, their use for amplification of these retroviruses and for in vitro diagnosis of these viruses caused infection
EP07025195A EP2011888B1 (en) 1989-06-02 1990-06-05 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses
JP50891190A JP3428012B2 (en) 1989-06-02 1990-06-05 Nucleotide sequences from the genomes of HIV-1, HIV-2 and SIV type retroviruses, and especially these for amplification of the genomes of these retroviruses and for "in vitro" diagnosis of infection by these viruses Application of array of
DE69033311T DE69033311T2 (en) 1989-06-02 1990-06-05 Nucleotide sequences of the genome of retroviruses of the HIV-1, HIV-2 and SIV types, their uses for the amplification of these genomes and the in vitro diagnosis of these viral infections
AT07025195T ATE466111T1 (en) 1989-06-02 1990-06-05 NUCLEOTIDE SEQUENCES OF THE GENOME OF RETROVIRUSES OF THE TYPE HIV-1, HIV-2 AND SIV AND THEIR APPLICATIONS, IN PARTICULAR FOR THE AMPLIFICATION OF THE GENES OF THESE RETROVIRUSES AND FOR THE IN VITRO DIAGNOSTICS OF INFECTIONS CAUSED BY THESE VIRUSES
ES97110543T ES2262166T3 (en) 1989-06-02 1990-06-05 SYNTHESIS OF PROTEINS OR POLYPEPTIDES CODED BY A NUCLEOTIDIC SEQUENCE HIV-1, HIV-2 OR SIV.
US08/160,465 US5688637A (en) 1989-06-02 1993-12-02 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the disease due to these viruses
US08/472,928 US7078516B1 (en) 1989-06-02 1995-06-07 Nucleotide sequences derived from the genome of retroviruses of the hiv-1, hiv-2 and siv type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
US08/895,231 US5786177A (en) 1989-06-02 1997-07-16 Nucleotide sequences derived from the genome or retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
US09/092,077 US6194142B1 (en) 1989-06-02 1998-06-05 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2, and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses
JP11270165A JP2000093187A (en) 1989-06-02 1999-09-24 Immunogen compound containing translation product of nucleotide sequence from genom of hiv-1, hiv-2 and siv-type retrovirus
GR990403346T GR3032261T3 (en) 1989-06-02 1999-12-28 Nucleotide sequences of retroviral genomes of types HIV-I, HIV-2 and SIV, their uses for the amplification of these genomes and diagnosis in vitro of these viral infections.
US10/862,363 US7759477B2 (en) 1989-06-02 2004-06-08 HIV-1, HIV-2, and SIV pol nucleotide fragments
US11/203,127 US7777020B2 (en) 1989-06-02 2005-08-15 Nucleotide sequences derived from the env gene of HIV-1
HK07103317.3A HK1097574A1 (en) 1989-06-02 2006-09-21 Nucleotide sequences derived from the genomes of the retroviruses hiv-1, hiv-2 and siv, and their application to the amplification of pol sequences in these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
HK09100744.0A HK1125136A1 (en) 1989-06-02 2006-09-21 Nucleotide sequences resulting from the genome of the hiv-1, hiv-2 and siv retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses
HK06110565.8A HK1092839A1 (en) 1989-06-02 2006-09-21 Nucleotide sequences derived from the genomes of the retroviruses hiv-1, hiv-2 and siv, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8907354A FR2647809B1 (en) 1989-06-02 1989-06-02 OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES

Publications (2)

Publication Number Publication Date
FR2647809A1 FR2647809A1 (en) 1990-12-07
FR2647809B1 true FR2647809B1 (en) 1991-09-20

Family

ID=9382331

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8907354A Expired - Lifetime FR2647809B1 (en) 1989-06-02 1989-06-02 OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES

Country Status (1)

Country Link
FR (1) FR2647809B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7568794A (en) * 1993-08-20 1995-03-21 St. Luke's-Roosevelt Hospital Center Hiv (vif)-related compositions, and prophylactic and therapeutic uses thereof
US20050222068A1 (en) 2003-10-23 2005-10-06 Mourich Dan V Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells
WO2010080554A1 (en) 2008-12-17 2010-07-15 Avi Biopharma, Inc. Antisense compositions and methods for modulating contact hypersensitivity or contact dermatitis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU606043B2 (en) * 1985-03-28 1991-01-31 F. Hoffmann-La Roche Ag Detection of viruses by amplification and hybridization
DE3752319T2 (en) * 1986-01-22 2001-03-15 Pasteur Institut Process for the recombinant production of HIV-2 proteins and cells that express HIV-2 proteins
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
EP0276302B1 (en) * 1986-08-11 1993-04-28 Siska Diagnostics,Inc. Nucleic acid probe assay methods and compositions
EP0269520A3 (en) * 1986-11-21 1988-08-24 Institut Pasteur Retrovirus of the type hiv-2, susceptible to provoke aids, and its antigenic and nucleic-acid constituents
EP0272098A3 (en) * 1986-12-15 1990-06-06 City Of Hope National Medical Center Method for amplification and detection of rna sequences
AU608294B2 (en) * 1987-01-16 1991-03-28 Institut Pasteur Peptides having immunological properties 2-hiv-2

Also Published As

Publication number Publication date
FR2647809A1 (en) 1990-12-07

Similar Documents

Publication Publication Date Title
WO1990015066A3 (en) Nucleotidic sequences resulting from the retrovirus gemone of the hiv-1, hiv-2, and siv type, and their applications, in particular for the amplification of the genomes of said retroviruses and for the in vitro diagnosis of infections caused by these viruses
FR2647810B1 (en) OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-2 AND SIV RETROVIRUSES, AND THEIR APPLICATIONS TO THE IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
ATE264914T1 (en) ANTIVIRAL PROTEINS, DNA CODING THEREOF, AND USE THEREOF
CA2271622A1 (en) Antiviral agents from plant extracts and use for treatment of viral infections
FR2647809B1 (en) OLIGONUCLEOTIDE PRIMERS FOR THE AMPLIFICATION OF THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES AND THEIR APPLICATIONS TO IN VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES
DE69403063T2 (en) AGAINST VIRUS-ACTIVE NAPHTOCHINONE COMPOUNDS, COMPOSITIONS AND THEIR USE
CA2195125A1 (en) Difluorostatone antiviral agents
JP2002508338A5 (en)
FR2652091B1 (en) NUCLEOTIDE SEQUENCES ARISING FROM THE GENOME OF HIV-1, HIV-2 AND SIV RETROVIRUSES, AND THEIR APPLICATIONS IN PARTICULAR FOR THE AMPLIFICATION OF THE GENOMES OF THESE RETROVIRUSES AND FOR THE IN-VITRO DIAGNOSIS OF INFECTIONS DUE TO THESE VIRUSES.
Chang et al. Dextran sulfate as an inhibitor against the human immunodeficiency virus
DeVICO et al. High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals
US5596018A (en) Antiviral agents against aids-causing virus
FR2614025B1 (en) PEPTIDES LIKELY TO BE RECOGNIZED BY ANTIBODIES INDUCED AGAINST HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
FR2610632B1 (en) CHARACTERISTIC PEPTIDES OF HUMAN IMMUNODEFICIENCY RETROVIRUSES (HIV VIRUSES) THEIR APPLICATIONS IN THE DIAGNOSIS OF INFECTIONS DUE TO CERTAIN OF THESE VIRUSES AND, IF NECESSARY, IN VACCINATION AGAINST AIDS
ATE284709T1 (en) VIRAL CHIMERAS FROM CAEV AND HIV-1 GENETIC ELEMENTS
DK0494317T3 (en) SIV-cpz ant retrovirus and its use
WO2000018433A3 (en) Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine
RU96116005A (en) STRAIN HOMINIS IMMUNODEFICITI VIRUS (HIV-I) HIV-I / RUSSIA / GM-12-95 (RU1295) SUBTYPE B FOR DIAGNOSTIC AND VACCINE DRUGS
JP2007515386A5 (en)
OA08716A (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retroviruses (HIV viruses), their applications in the diagnosis of infections due to certain of these viruses and, where appropriate, in vaccination against AIDS.
JPH03227925A (en) Antiviral agent against aids-causative virus
ATE185485T1 (en) MEDICINAL PRODUCTS TO PREVENT INFECTION WITH THE VIRUS THAT CAUSES AIDS
Scheibel Five-drug or six-drug antiretroviral therapy--conversation with Steven Scheibel, MD Interview by John S. James
WO1988008707A3 (en) Rubradirin derivatives for treatment of hiv infection
TH3782EX (en) Nucleosides that fight viruses

Legal Events

Date Code Title Description
CD Change of name or company name
CL Concession to grant licences